These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2886000

  • 1. Nine months' subcutaneous therapy with synthetic growth hormone releasing factor in children with short stature.
    Hümmelink R, Rohwedder R, Sippell WG.
    Acta Paediatr Scand Suppl; 1987; 331():48-52. PubMed ID: 2886000
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.
    Kirk JM, Trainer PJ, Majrowski WH, Murphy J, Savage MO, Besser GM.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):487-93. PubMed ID: 7955460
    [Abstract] [Full Text] [Related]

  • 5. The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature.
    Grossman A, Savage MO, Blacklay A, Ross RM, Plowman PN, Preece MA, Coy DH, Besser GM.
    Horm Res; 1985 Oct; 22(1-2):52-7. PubMed ID: 2863206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of growth hormone releasing hormone therapy and growth hormone therapy in growth hormone deficiency.
    Butenandt O, Staudt B.
    Eur J Pediatr; 1989 Feb; 148(5):393-5. PubMed ID: 2537727
    [Abstract] [Full Text] [Related]

  • 8. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
    Van Vliet G, Bosson D, Robyn C, Craen M, Malvaux P, Vanderschueren-Lodeweyckx M, Wolter R.
    Horm Res; 1985 Feb; 22(1-2):32-45. PubMed ID: 3928475
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency?
    Smith PJ, Brook CG.
    Arch Dis Child; 1988 Jun; 63(6):629-34. PubMed ID: 2898924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
    Dickerman Z, Guyda H, Tannenbaum GS.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):652-7. PubMed ID: 8257527
    [Abstract] [Full Text] [Related]

  • 13. Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects.
    Csizmadi I, Brazeau P, Serri O.
    Metabolism; 1989 Oct; 38(10):1016-21. PubMed ID: 2507875
    [Abstract] [Full Text] [Related]

  • 14. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Ross RJ, Rodda C, Tsagarakis S, Davies PS, Grossman A, Rees LH, Preece MA, Savage MO, Besser GM.
    Lancet; 1987 Jan 03; 1(8523):5-8. PubMed ID: 2879138
    [Abstract] [Full Text] [Related]

  • 15. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF.
    von Werder K, Losa M, Stalla GK, Bock L, Müller OA.
    Acta Neurochir (Wien); 1985 Jan 03; 75(1-4):81-7. PubMed ID: 2986424
    [Abstract] [Full Text] [Related]

  • 16. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE, Tauber MT, Coude FX, Arnone M, Morre M, Uboldi F, Barbeau C.
    J Clin Endocrinol Metab; 1987 Aug 03; 65(2):268-74. PubMed ID: 3110202
    [Abstract] [Full Text] [Related]

  • 17. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Lustig RH, Schriock EA, Kaplan SL, Grumbach MM.
    Pediatrics; 1985 Aug 03; 76(2):274-9. PubMed ID: 3927254
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Silver-Russell type dwarfism with human growth hormone: effects on serum somatomedin-C levels and on longitudinal growth studied by knemometry.
    Partsch CJ, Hermanussen M, Sippell WG.
    Acta Endocrinol Suppl (Copenh); 1986 Aug 03; 279():139-46. PubMed ID: 3465155
    [Abstract] [Full Text] [Related]

  • 19. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM, Shalet SM.
    Clin Endocrinol (Oxf); 1997 May 03; 46(5):571-8. PubMed ID: 9231053
    [Abstract] [Full Text] [Related]

  • 20. Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. Venezuelan Collaborative Study Group.
    Lanes R, Carrillo E.
    J Pediatr Endocrinol; 1994 May 03; 7(4):303-8. PubMed ID: 7735367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.